Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Hamilton

Showing results (131-140 of 245) with videos related to

Pageof 25
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 20, 2025
Prostate-specific antigen density does not predict metastatic disease on PSMA-PET in high-risk prostate cancer patients with negative conventional imagingRavi Kumar, Katherine Lajkosz, Ur Metser, et al.
Cancer Medicine|September 6, 2025
Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer SurvivorsSwetha Nakshatri, Paul C Dinh, Lawrence H Einhorn, et al.
Urologic Oncology|August 8, 2017
Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicionBimal Bhindi, Haiyan Jiang, Cedric Poyet, et al.
Current Oncology (Toronto, Ont.)|February 24, 2021
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular CancerDomen Ribnikar, Igor Stukalin, Philippe L Bedard, et al.
European Urology|August 17, 2016
Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular CancerMadhur Nayan, Michael A S Jewett, Ali Hosni, et al.
International Journal of Radiation Oncology, Biology, Physics|January 8, 2025
Clinical Outcomes of Stage IIA/IIB Seminoma Treated With Radiation Therapy and Chemotherapy: Should Regional Therapy be Considered the Preferred Treatment Approach?Rachel M Glicksman, Di Maria Jiang, Philippe L Bedard, et al.
Urology|March 27, 2016
Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade, and Overall Recurrence Risk in Men Undergoing Radical ProstatectomyBimal Bhindi, Wen Y Xie, Girish S Kulkarni, et al.
Urologic Oncology|July 10, 2019
Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysisMadhur Nayan, Shreya Jalali, Anil Kapoor, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 25, 2018
Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provincesDixon T S Woon, Thenappan Chandrasekar, Lorne Aaron, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
Renal Impairment and Late Toxicities Comparing Contemporary Chemotherapy Regimens for Testicular Cancer in a Real-World SettingSarah L Kerns, Paul C Dinh, Patrick O Monahan, et al.
Pageof 25

Showing results (131-140 of 245) with videos related to

Sort By:
Pageof 25
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 20, 2025
Prostate-specific antigen density does not predict metastatic disease on PSMA-PET in high-risk prostate cancer patients with negative conventional imagingRavi Kumar, Katherine Lajkosz, Ur Metser, et al.
Cancer Medicine|September 6, 2025
Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer SurvivorsSwetha Nakshatri, Paul C Dinh, Lawrence H Einhorn, et al.
Urologic Oncology|August 8, 2017
Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicionBimal Bhindi, Haiyan Jiang, Cedric Poyet, et al.
Current Oncology (Toronto, Ont.)|February 24, 2021
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular CancerDomen Ribnikar, Igor Stukalin, Philippe L Bedard, et al.
European Urology|August 17, 2016
Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular CancerMadhur Nayan, Michael A S Jewett, Ali Hosni, et al.
International Journal of Radiation Oncology, Biology, Physics|January 8, 2025
Clinical Outcomes of Stage IIA/IIB Seminoma Treated With Radiation Therapy and Chemotherapy: Should Regional Therapy be Considered the Preferred Treatment Approach?Rachel M Glicksman, Di Maria Jiang, Philippe L Bedard, et al.
Urology|March 27, 2016
Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade, and Overall Recurrence Risk in Men Undergoing Radical ProstatectomyBimal Bhindi, Wen Y Xie, Girish S Kulkarni, et al.
Urologic Oncology|July 10, 2019
Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysisMadhur Nayan, Shreya Jalali, Anil Kapoor, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 25, 2018
Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provincesDixon T S Woon, Thenappan Chandrasekar, Lorne Aaron, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
Renal Impairment and Late Toxicities Comparing Contemporary Chemotherapy Regimens for Testicular Cancer in a Real-World SettingSarah L Kerns, Paul C Dinh, Patrick O Monahan, et al.
Pageof 25